Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
My Bing
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
Trending on Bing
Surprise 'SNL' cameo
Demands Jack Smith's arrest
Alleged murder-for-hire plot
Buffett rings the alarm on AI
Cancels Mexico shows
Detects weather on exoplanet
Graduation briefly disrupted
Recovering from surgery
Addresses campus protests
WH perimeter gate crash
Private jet crash landing
Simulcast to end in 2024
Tony-winning producer dies
Long Beach shooting, 7 hurt
Inducted into Soccer HOF
Putin attends Easter service
US artist Frank Stella dies
Campaign raised $76M+?
‘Megalopolis' first teaser
To close operations in ISR
Zelenskyy on RU wanted list?
Wins fourth LIV title
All about '24 Met Gala theme
Israeli forces conduct raids
Lands $10.4M opening day
'Just as disappointed as you'
Suspended from practice
Wins 2024 Kentucky Derby
Hundreds rescued in Texas
Issues 72-hour lockout
Brown announces retirement
Former Lakers player dies
New AI-generated summaries
Gaza in 'full-blown famine'
Aviation milestone setter dies
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
California, Amneal Pharmaceuticals and Narcan
FDA approves Amneal's generic version of OTC Narcan
The FDA has approved Amneal Pharmaceuticals’ ( NASDAQ: AMRX) OTC Naloxone HCl nasal spray, a generic version of the opioid overdose medication OTC Narcan. The company said OTC Naloxone is now available in the US. Narcan is marketed by drugmaker Emergent BioSolutions ( EBS ).
California joining with N.J. company to buy generic opioid overdose reversal drug Narcan
California is partnering with a New Jersey-based pharmaceutical company to purchase a generic version of Narcan, the most well-known version of naloxone that can save a person's life during an opioid overdose.
California will supply first responders, universities with opioid overdose reversal drug for free
CalRx, the state's generic-drug initiative, will partner with Amneal Pharmaceuticals of New Jersey to buy over-the-counter naloxone for $24 a pack.
3d
on MSN
FDA approves over-the-counter sales of Narcan. But would you know what to do to save a life?
In a move that health experts say may reduce the number of fentanyl deaths, the FDA has approved over-the-counter sales of ...
MedPage Today on MSN
3d
Narcan May Have Moved Over-the-Counter, but It’s Still Underutilized
After its approval, the first OTC product didn't actually hit store shelves until September 2023. This followed decades of ...
Health Affairs
6d
Low-Dose Ketamine Is An Effective Non-Opioid Analgesic: The FDA Should Authorize Its Use
Repurposing a Food and Drug Administration (
FDA
)-
approved
drug for a new use has been informally practiced for years. In ...
11d
on MSN
How Wake schools aim to ‘be as ready as we can be’ when opioid overdoses happen
Narcan is the FDA-approved nasal form of naloxone for the emergency treatment of a known or suspected opioid overdose. The ...
abc7NY
5d
California partners with New Jersey company to make generic Narcan overdose reversal drug
SACRAMENTO, Calif. -- California will soon begin selling its own generic version of
Narcan
- the drug that can save someone ...
11d
Amneal Pharmaceuticals Shares Rise 9% After FDA Approves Naloxone Spray
By Chris Wack Amneal Pharmaceuticals shares were up 9% after the Food and Drug Administration approved an abbreviated new drug application ...
11d
Amneal's OTC Naloxone Nasal Spray Receives FDA Approval For Opioid Overdose Emergency Treatment
Amneal Pharmaceuticals, Inc. (AMRX) announced on Wednesday that it has received FDA approval for its Over the Counter Naloxone ...
Monthly Prescribing Reference
11d
High-Dose Naloxone Nasal Spray Rezenopy Gets FDA Approval
The nasal spray product delivers 10mg of
naloxone
hydrochloride in a single dose. The Food and Drug Administration (
FDA
) has
approved
Rezenopy (
naloxone
hydrochloride) nasal spray for the ...
3h
Opioid Use Disorder Market Expected To Reach USD 6.15 Billion By 2030: SNS Insider
The surge in opioid addiction cases globally has been a primary driver for the expansion of the OUD market. Factors such as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback